Related Experiment Video

Updated: Oct 1, 2026

Intravenous Injections in Neonatal Mice
05:17

Intravenous Injections in Neonatal Mice

Published on: November 11, 2014

[Chemotherapy treatment of infectious diseases in infancy and early childhood]

F Vassella, J Pfenninger

    Schweizerische Medizinische Wochenschrift
    |March 1, 1975
    PubMed

    Insights

    Pediatric antibiotic therapy requires careful dosing based on age and weight, considering immature infant systems. Organ vulnerability, like tetracycline staining, highlights age-dependent risks in children.

    Area of Science:

    • Pediatric Pharmacology
    • Chemotherapeutic Agents
    • Drug Metabolism

    Context:

    • Antibiotic and chemotherapeutic agent use in pediatric patients.
    • Consideration of physiological differences in infants, including enzyme system immaturity and excretion mechanisms.
    • Age-dependent organ vulnerability, exemplified by tetracycline staining.

    Purpose:

    • To discuss specific pediatric considerations for antibiotic and chemotherapeutic agent therapy.
    • To highlight challenges in early infancy drug administration.
    • To provide a selection of suitable antibiotics for ambulatory pediatric care.

    Summary:

    • Therapy with antibiotics and chemotherapeutic agents in pediatric patients necessitates adjustments based on age, body weight, and body surface area.
    • Immature enzyme systems and excretion mechanisms in early infancy present unique challenges.
    • Tetracycline staining serves as a key example of age-dependent organ vulnerability, underscoring the need for tailored therapeutic approaches.

    Impact:

    • Informs pediatricians and pharmacists on safe and effective drug dosing in children.
    • Raises awareness of specific risks associated with certain medications in infants.
    • Provides guidance on antibiotic selection for outpatient pediatric settings.

    More Related Videos

    Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia08:31

    Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

    Published on: October 17, 2025

    A Neonatal Intravenous Transplant Model for Assessment of Early-Life Immune Activities Against Cancer Cells06:32

    A Neonatal Intravenous Transplant Model for Assessment of Early-Life Immune Activities Against Cancer Cells

    Published on: June 26, 2026

    Related Concept Videos

    Cancer Therapies02:49

    Cancer Therapies

    Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
    However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
    Combination Therapies and Personalized Medicine02:50

    Combination Therapies and Personalized Medicine

    Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
    The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
    Immunodeficiency Diseases01:25

    Immunodeficiency Diseases

    Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
    There are three main causes of immunodeficiency disorders...
    Tumor Immunotherapy01:27

    Tumor Immunotherapy

    Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
    Microorganisms in Medicine and Therapeutics01:29

    Microorganisms in Medicine and Therapeutics

    Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
    Cryptococcal Meningitis01:27

    Cryptococcal Meningitis

    Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...